Regenerative Medical Solutions: Funding, Investors & Team (Sep 2026)
Regenerative Medical Solutions is a company that creates regenerative medical products for the treatment of diabetes. One of their main products, ProgenMix, is a solution that produces pancreatic progenitor cells and various types of endocrine cells. ProgenMix is compatible with different human ESC and iPSC lines and is widely used for drug testing and assay development. In addition to product development, the company also offers consulting services and strives to develop new treatments and applications specifically for diabetes patients. Their ProgenMix solution is versatile and can be used in various scientific research applications, such as assessing the potential toxiUK candidate drugs. Established in 2010, Regenerative Medical Solutions is located in Chicago, Illinois.
Regenerative Medical Solutions has raised $6.8M across 2 funding rounds on record, the most recent an undisclosed round of $1.8M announced in Oct 2025.
That round is below the $8.0M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
Regenerative Medical Solutions Company Profile and Key Stats
Latest funding round on record: Oct 2025.
Regenerative Medical Solutions Funding Rounds
Regenerative Medical Solutions raised $5.0M in an undisclosed round announced in Aug 2023.
2.2 years later, an undisclosed round of $1.8M was announced in Oct 2025.
Regenerative Medical Solutions Founders and Leadership Team
Contact details for the Regenerative Medical Solutions team: 1 of 2 have an email address on file.
Start 14-day free trial →Regenerative Medical Solutions Funding Compared to Other Biotechnology Startups
Regenerative Medical Solutions' latest round of $1.8M is below the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Regenerative Medical Solutions in Biotechnology and Chicago
Companies Similar to Regenerative Medical Solutions
Superluminal Medicines is a biotech company that specializes in rapidly developing new drugs through a…
Senticell's mission is to fully harness the unique immune and genetic functions of RBC to transform and treat…
ImmunoPhotonics, Inc. develops immunotherapy-based treatments for cancer. ImmunoPhotonics, Inc. has a…
EIT Pharma is a commercial-stage biotechnology company focuses on developing and commercializing…
Halia Therapeutics is a biopharmaceutical company in the preclinical stage that is developing new treatments…
Noveome Biotherapeutics, Inc. is an advanced biopharmaceutical company that focuses on groundbreaking…
XiltriX North America is an information technology company that specializes in monitoring, predictive…
Novir is an emerging diagnostic biotechnology company with an unmatched team of professionals and trusted…
Abcuro’s mission is to develop a new class of immune-modulatory bio-therapeutics for treating both…
Georgiamune Inc. is a privately-owned biotechnology company that specializes in advanced immunotherapy…
Bridge to Life was founded with the mission of improving organ transplants by licensing and developing new…
InduPro is a biotechnology firm that focuses on protein therapeutics and technologies related to cell-surface…
Regenerative Medical Solutions Funding FAQs
What does Regenerative Medical Solutions do?
Regenerative Medical Solutions is a company that creates regenerative medical products for the treatment of diabetes. One of their main products, ProgenMix, is a solution that produces pancreatic progenitor cells and various types of endocrine cells. ProgenMix is compatible with different human ESC and iPSC lines and is widely used for drug testing and assay development. In addition to product development, the company also offers consulting services and strives to develop new treatments and applications specifically for diabetes patients. Their ProgenMix solution is versatile and can be used in various scientific research applications, such as assessing the potential toxiUK candidate drugs. Established in 2010, Regenerative Medical Solutions is located in Chicago, Illinois.
How much funding has Regenerative Medical Solutions raised?
Regenerative Medical Solutions has raised $6.8M across 2 rounds on record. The most recent is an undisclosed round of $1.8M announced in Oct 2025.
When did Regenerative Medical Solutions last raise funding?
Regenerative Medical Solutions' most recent funding round on record is an undisclosed round of $1.8M, announced in Oct 2025.
Who founded Regenerative Medical Solutions?
FundedIQ lists Jon S Odorico (Founder) at Regenerative Medical Solutions.
Who is the CEO of Regenerative Medical Solutions?
Anthony D Kolton is listed as CEO at Regenerative Medical Solutions.
Where is Regenerative Medical Solutions headquartered?
Regenerative Medical Solutions is based in Chicago, Illinois, United States.
How many employees does Regenerative Medical Solutions have?
Regenerative Medical Solutions is in the 1-10 employee band.
How does Regenerative Medical Solutions' funding compare to other Biotechnology startups?
Regenerative Medical Solutions' latest round of $1.8M is below the $8.0M median round size for Biotechnology companies on FundedIQ across 4,182 tracked companies over the last two years.
About FundedIQ's Regenerative Medical Solutions Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Regenerative Medical Solutions is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.
Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.